173 related articles for article (PubMed ID: 20152224)
1. Myocardial infarction and incidence of type 2 diabetes mellitus. Is admission blood glucose an independent predictor for future type 2 diabetes mellitus?
Meisinger C; Beck J; Heier M; Hörmann A; Kuch B; Sietas G; Koenig W;
Am Heart J; 2010 Feb; 159(2):258-63. PubMed ID: 20152224
[TBL] [Abstract][Full Text] [Related]
2. Effect of blood glucose concentrations on admission in non-diabetic versus diabetic patients with first acute myocardial infarction on short- and long-term mortality (from the MONICA/KORA Augsburg Myocardial Infarction Registry).
Beck JA; Meisinger C; Heier M; Kuch B; Hörmann A; Greschik C; Koenig W
Am J Cardiol; 2009 Dec; 104(12):1607-12. PubMed ID: 19962462
[TBL] [Abstract][Full Text] [Related]
3. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus.
Stranders I; Diamant M; van Gelder RE; Spruijt HJ; Twisk JW; Heine RJ; Visser FC
Arch Intern Med; 2004 May; 164(9):982-8. PubMed ID: 15136307
[TBL] [Abstract][Full Text] [Related]
4. IGF binding protein 1 predicts cardiovascular morbidity and mortality in patients with acute myocardial infarction and type 2 diabetes.
Wallander M; Norhammar A; Malmberg K; Ohrvik J; Rydén L; Brismar K
Diabetes Care; 2007 Sep; 30(9):2343-8. PubMed ID: 17563335
[TBL] [Abstract][Full Text] [Related]
5. Leptin: a predictor of abnormal glucose tolerance and prognosis in patients with myocardial infarction and without previously known Type 2 diabetes.
Wallander M; Söderberg S; Norhammar A
Diabet Med; 2008 Aug; 25(8):949-55. PubMed ID: 18959608
[TBL] [Abstract][Full Text] [Related]
6. Fasting glucose in acute myocardial infarction: incremental value for long-term mortality and relationship with left ventricular systolic function.
Aronson D; Hammerman H; Kapeliovich MR; Suleiman A; Agmon Y; Beyar R; Markiewicz W; Suleiman M
Diabetes Care; 2007 Apr; 30(4):960-6. PubMed ID: 17392556
[TBL] [Abstract][Full Text] [Related]
7. Glucose levels compared with diabetes history in the risk assessment of patients with acute myocardial infarction.
Goyal A; Mehta SR; Gerstein HC; Díaz R; Afzal R; Xavier D; Zhu J; Pais P; Lisheng L; Kazmi KA; Zubaid M; Piegas LS; Widimsky P; Budaj A; Avezum A; Yusuf S
Am Heart J; 2009 Apr; 157(4):763-70. PubMed ID: 19332208
[TBL] [Abstract][Full Text] [Related]
8. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes.
Kosiborod M; Rathore SS; Inzucchi SE; Masoudi FA; Wang Y; Havranek EP; Krumholz HM
Circulation; 2005 Jun; 111(23):3078-86. PubMed ID: 15939812
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of admission glucose in non-diabetic patients with myocardial infarction.
Timmer JR; van der Horst IC; Ottervanger JP; Henriques JP; Hoorntje JC; de Boer MJ; Suryapranata H; Zijlstra F;
Am Heart J; 2004 Sep; 148(3):399-404. PubMed ID: 15389225
[TBL] [Abstract][Full Text] [Related]
10. Relationship between blood glucose on admission and prognosis in patients with acute myocardial infarction treated with percutaneous coronary intervention.
Gasior M; Stasik-Pres G; Pres D; Lech P; Gierlotka M; Lekston A; Hawranek M; Tajstra M; Kalarus Z; Poloński L
Kardiol Pol; 2007 Sep; 65(9):1031-8; discussion 1039-40. PubMed ID: 17975750
[TBL] [Abstract][Full Text] [Related]
11. Admission glucose concentrations independently predict early and late mortality in patients with acute myocardial infarction treated by primary or rescue percutaneous coronary intervention.
Straumann E; Kurz DJ; Muntwyler J; Stettler I; Furrer M; Naegeli B; Frielingsdorf J; Schuiki E; Mury R; Bertel O; Spinas GA
Am Heart J; 2005 Nov; 150(5):1000-6. PubMed ID: 16290985
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease.
Tenenbaum A; Motro M; Fisman EZ; Schwammenthal E; Adler Y; Goldenberg I; Leor J; Boyko V; Mandelzweig L; Behar S
Circulation; 2004 May; 109(18):2197-202. PubMed ID: 15123532
[TBL] [Abstract][Full Text] [Related]
13. Differential impact of admission C-reactive protein levels on 28-day mortality risk in patients with ST-elevation versus non-ST-elevation myocardial infarction (from the Monitoring Trends and Determinants on Cardiovascular Diseases [MONICA]/Cooperative Health Research in the Region of Augsburg [KORA] Augsburg Myocardial Infarction Registry).
Kuch B; von Scheidt W; Kling B; Heier M; Hoermann A; Meisinger C
Am J Cardiol; 2008 Nov; 102(9):1125-30. PubMed ID: 18940277
[TBL] [Abstract][Full Text] [Related]
14. Initial serum glucose level as a prognostic factor in the first acute myocardial infarction.
Hsu CW; Chen HH; Sheu WH; Chu SJ; Shen YS; Wu CP; Chien KL
Ann Emerg Med; 2007 May; 49(5):618-26. PubMed ID: 17178170
[TBL] [Abstract][Full Text] [Related]
15. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
Schramm TK; Gislason GH; Køber L; Rasmussen S; Rasmussen JN; Abildstrøm SZ; Hansen ML; Folke F; Buch P; Madsen M; Vaag A; Torp-Pedersen C
Circulation; 2008 Apr; 117(15):1945-54. PubMed ID: 18378618
[TBL] [Abstract][Full Text] [Related]
16. Does glucose level at hospital discharge predict one-year mortality in patients with diabetes mellitus treated with percutaneous coronary intervention for ST-segment elevation myocardial infarction?
Gasior M; Pres D; Stasik-Pres G; Lech P; Gierlotka M; Lekston A; Hawranek M; Tajstra M; Kalarus Z; Poloński L
Kardiol Pol; 2008 Jan; 66(1):1-8; discussion 9-11. PubMed ID: 18266182
[TBL] [Abstract][Full Text] [Related]
17. Impaired fasting glucose cutoff value of 5.6 mmol/l combined with other cardiovascular risk markers is a better predictor for incident Type 2 diabetes than the 6.1 mmol/l value: Tehran lipid and glucose study.
Harati H; Hadaegh F; Tohidi M; Azizi F
Diabetes Res Clin Pract; 2009 Jul; 85(1):90-5. PubMed ID: 19414206
[TBL] [Abstract][Full Text] [Related]
18. Admission blood glucose and adverse outcomes in non-diabetic patients with myocardial infarction in the reperfusion era.
Meisinger C; Hörmann A; Heier M; Kuch B; Löwel H
Int J Cardiol; 2006 Nov; 113(2):229-35. PubMed ID: 16359742
[TBL] [Abstract][Full Text] [Related]
19. Smoking as an independent risk factor for myocardial infarction or stroke in type 2 diabetes: a report from the Swedish National Diabetes Register.
Nilsson PM; Cederholm J; Eeg-Olofsson K; Eliasson B; Zethelius B; Fagard R; Gudbjörnsdóttir S;
Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):506-12. PubMed ID: 19561510
[TBL] [Abstract][Full Text] [Related]
20. Impaired fasting glucose and outcomes of ST-elevation acute coronary syndrome treated with primary percutaneous intervention among patients without previously known diabetes mellitus.
Porter A; Assali AR; Zahalka A; Iakobishvili Z; Brosh D; Lev EI; Mager A; Battler A; Kornowski R; Hasdai D
Am Heart J; 2008 Feb; 155(2):284-9. PubMed ID: 18215598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
